Home/Targepeutics/Sil Lutkewitte
SL

Sil Lutkewitte

CEO, Chair - Board of Directors

Targepeutics

Therapeutic Areas

Targepeutics Pipeline

DrugIndicationPhase
GB-13Glioblastoma (GBM) and Diffuse Midline Glioma (DMG)Pre-clinical